<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta name="description" content="InSynBio Smart CAR-T Design Service â€” AI-driven end-to-end engineering for CAR-T, CAR-NK, and CAR-M. From target selection to sequence design and CRO validation.">
  <meta name="keywords" content="CAR-T design, CAR-NK, CAR-M, smart CAR-T, antibody engineering, immunotherapy, InSynBio, AI drug design">
  <title>Smart CAR-T Design | InSynBio â€” AI for Life Sciences</title>
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Cormorant+Garamond:ital,wght@0,500;0,600;0,700;1,500&family=Noto+Sans+SC:wght@400;500&display=swap" rel="stylesheet">
  <style>
    :root { --primary: #0d9488; --primary-dark: #0f766e; --text: #1f2937; --text-muted: #6b7280; --border: #e5e7eb; --bg: #ffffff; --bg-alt: #f9fafb; }
    * { box-sizing: border-box; }
    body { margin: 0; font-family: 'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif; font-size: 16px; line-height: 1.6; color: var(--text); background: var(--bg-alt); }
    /* T-shaped: top header + sidebar + main */
    .top-header { display: flex; align-items: center; justify-content: space-between; padding: 10px 24px; background: var(--bg); border-bottom: 1px solid var(--border); flex-shrink: 0; gap: 16px; flex-wrap: wrap; }
    .top-header .brand { font-family: 'Cormorant Garamond', Georgia, serif; font-weight: 600; font-size: 24px; letter-spacing: -0.02em; display: flex; align-items: center; }
    .top-header .brand a { text-decoration: none; color: inherit; display: flex; align-items: center; gap: 9px; }
    .top-header .brand .syn { color: var(--primary); font-style: italic; font-weight: 700; }
    .top-header .slogan { font-size: 13px; color: var(--text-muted); margin-left: 0; padding-left: 14px; border-left: 1px solid var(--border); font-family: 'Inter', sans-serif; white-space: nowrap; }
    .top-header-nav { display: flex; align-items: center; gap: 8px; flex: 1; justify-content: center; }
    .top-header-nav a { padding: 8px 14px; font-size: 14px; color: var(--text-muted); text-decoration: none; border-radius: 6px; transition: all 0.2s; }
    .top-header-nav a:hover { color: var(--primary); background: var(--bg-alt); }
    .nav-dropdown { position: relative; }
    .nav-dropdown > a::after { content: ' â–¾'; font-size: 10px; opacity: 0.7; }
    .nav-dropdown .dropdown-menu { position: absolute; top: 100%; left: 0; min-width: 160px; padding: 6px 0; background: var(--bg); border: 1px solid var(--border); border-radius: 8px; box-shadow: 0 4px 12px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-4px); transition: all 0.2s; z-index: 100; }
    .nav-dropdown:hover .dropdown-menu,
    .nav-dropdown:focus-within .dropdown-menu { opacity: 1; visibility: visible; transform: translateY(0); }
    .nav-dropdown .dropdown-menu a { display: block; padding: 10px 16px; color: var(--text); text-decoration: none; line-height: 1.4; border-radius: 0; white-space: normal; }
    .nav-dropdown .dropdown-menu a:hover { background: var(--bg-alt); }
    .nav-dropdown .dropdown-menu a .menu-title { display: block; font-weight: 600; font-size: 14px; color: var(--text); }
    .nav-dropdown .dropdown-menu a:hover .menu-title { color: var(--primary); }
    .nav-dropdown .dropdown-menu a .menu-desc { display: block; font-size: 12px; color: var(--text-muted); font-weight: 400; margin-top: 2px; }
    .top-header-nav a.cta { background: var(--primary); color: #fff; font-weight: 500; }
    .top-header-nav a.cta:hover { background: var(--primary-dark); color: #fff; }
    .top-header .header-right { display: flex; align-items: center; gap: 16px; }
    .top-header .lang-switch { margin: 0; }
    .page-wrap { display: flex; min-height: calc(100vh - 57px); }
    .sidebar { width: 260px; flex-shrink: 0; background: var(--bg); border-right: 1px solid var(--border); padding: 28px 0; position: sticky; top: 0; height: 100vh; overflow-y: auto; }
    .sidebar h3 { font-size: 12px; font-weight: 600; color: var(--text-muted); margin: 0 24px 12px; padding-top: 4px; text-transform: uppercase; letter-spacing: 1px; }
    .sidebar nav a { display: flex; align-items: center; padding: 12px 24px; color: var(--text); text-decoration: none; font-size: 15px; transition: all 0.2s; border-left: 3px solid transparent; }
    .sidebar nav a:hover { background: var(--bg-alt); color: var(--primary); }
    .sidebar nav a.active { background: #f0fdfa; color: var(--primary-dark); border-left-color: var(--primary); font-weight: 500; }
    .nav-icon { width: 18px; height: 18px; margin-right: 10px; opacity: 0.7; flex-shrink: 0; }
    .main { flex: 1; padding: 36px 48px 64px; max-width: 920px; }
    .main h1 { font-size: 32px; font-weight: 700; color: var(--text); margin: 0 0 12px; letter-spacing: -0.02em; }
    .main .subtitle { font-size: 17px; color: var(--text-muted); margin-bottom: 4px; }
    .main h2 { font-size: 21px; font-weight: 600; color: var(--text); margin: 36px 0 16px; padding-top: 28px; border-top: 1px solid var(--border); }
    .main h2:first-of-type { margin-top: 0; padding-top: 0; border-top: none; }
    .main h2#library { font-size: 26px; font-weight: 700; }
    .h2-icon { display: inline-flex; align-items: center; justify-content: center; width: 32px; height: 32px; margin-right: 10px; border-radius: 8px; background: rgba(13,148,136,0.12); color: var(--primary); vertical-align: middle; }
    .main p, .main ul, .main li { margin: 0 0 16px; color: var(--text); font-size: 16px; }
    .main ul { padding-left: 24px; }
    .main li { margin-bottom: 10px; }
    .main .input-note { font-size: 14px; color: var(--text-muted); margin-top: 8px; }
    .form-section { background: var(--bg); border-radius: 12px; padding: 32px; margin-top: 32px; box-shadow: 0 1px 3px rgba(0,0,0,0.06); border: 1px solid var(--border); }
    .form-row { display: flex; gap: 24px; margin-bottom: 24px; flex-wrap: wrap; }
    .form-group { flex: 1; min-width: 180px; }
    .form-group.full { flex: 1 1 100%; }
    .form-group label { display: block; font-weight: 500; margin-bottom: 8px; color: var(--text); font-size: 14px; }
    .form-group input, .form-group select, .form-group textarea { width: 100%; padding: 12px 14px; border: 1px solid var(--border); border-radius: 8px; font-size: 14px; font-family: inherit; }
    .form-group textarea { min-height: 100px; resize: vertical; }
    .form-group textarea.seq { font-family: 'Consolas', 'Monaco', monospace; font-size: 13px; min-height: 80px; }
    .form-group input:focus, .form-group select:focus, .form-group textarea:focus { outline: none; border-color: var(--primary); box-shadow: 0 0 0 2px rgba(13,148,136,0.15); }
    .form-group .hint { font-size: 13px; color: var(--text-muted); margin-top: 6px; }
    .form-group .hint a { color: var(--primary); }
    .btn { padding: 14px 28px; background: var(--primary); color: #fff; border: none; border-radius: 8px; font-size: 15px; font-weight: 500; cursor: pointer; }
    .btn:hover { background: var(--primary-dark); }
    .check-group { display: flex; flex-wrap: wrap; gap: 16px; margin: 16px 0; }
    .check-item { display: flex; align-items: center; gap: 10px; }
    .check-item input { width: 18px; height: 18px; }
    .check-item label { margin: 0; font-weight: 400; cursor: pointer; }
    .breadcrumb { font-size: 14px; color: var(--text-muted); margin-bottom: 28px; }
    .breadcrumb a { color: var(--primary); text-decoration: none; }
    .breadcrumb a:hover { text-decoration: underline; }
    .breadcrumb span { color: #d1d5db; margin: 0 8px; }
    .table-wrap { overflow-x: auto; margin: 24px 0; border-radius: 6px; border: 1px solid var(--border); }
    .main table { min-width: 100%; background: var(--bg); border-collapse: separate; border-spacing: 0; border-radius: 8px; overflow: hidden; border: 1px solid var(--border); }
    .main table th, .main table td { padding: 16px 20px; border: none; border-bottom: 1px solid var(--border); font-size: 15px; color: var(--text); text-align: left; }
    .main table th { background: #f8fafc; font-weight: 700; color: #0f172a; text-transform: uppercase; font-size: 14px; letter-spacing: 0.05em; }
    .main table tr:last-child td { border-bottom: none; }
    .main table tr:hover td { background-color: #f9fafb; }
    .main table th:nth-child(4), .main table td:nth-child(4) { word-break: break-word; white-space: normal; min-width: 180px; }
    .main table .status-link { display: inline-block; font-size: 12px; font-weight: 600; color: var(--primary); background: rgba(13,148,136,0.08); padding: 2px 9px; border-radius: 20px; text-decoration: none; }
    .main table .status-link:hover { background: rgba(13,148,136,0.15); color: var(--primary-dark); }
    .disclaimer { font-size: 14px; color: var(--text-muted); font-style: italic; margin-top: 12px; padding: 12px 16px; background: #fffbeb; border-left: 4px solid #f59e0b; border-radius: 0 6px 6px 0; }
    .file-upload-wrap { display: flex; align-items: center; gap: 12px; flex-wrap: wrap; }
    .file-input-hidden { position: absolute; width: 0.1px; height: 0.1px; opacity: 0; overflow: hidden; z-index: -1; }
    .file-upload-btn { padding: 10px 18px; background: var(--bg-alt); border: 1px solid var(--border); border-radius: 6px; font-size: 14px; cursor: pointer; color: var(--text); }
    .file-upload-btn:hover { border-color: var(--primary); color: var(--primary); }
    .file-upload-name { font-size: 14px; color: var(--text-muted); }
    .brand-logo { font-family: 'Cormorant Garamond', Georgia, serif; font-weight: 600; font-size: 28px; letter-spacing: -0.02em; line-height: 1.2; margin-bottom: 24px; padding: 0 24px; }
    .brand-logo a { text-decoration: none; color: inherit; display: inline-block; transition: opacity 0.2s; }
    .brand-logo a:hover { opacity: 0.85; }
    .brand-logo .in { color: var(--text); }
    .brand-logo .syn { color: var(--primary); font-style: italic; font-weight: 700; }
    .brand-logo .bio { color: var(--text); }
    .brand-logo .tagline { font-family: 'Inter', sans-serif; font-size: 10px; font-weight: 500; color: var(--text-muted); text-transform: uppercase; letter-spacing: 1.5px; margin-top: 4px; font-style: normal; }
    .lang-switch { display: flex; gap: 4px; margin: 0 24px 20px; }
    .lang-switch button { padding: 6px 12px; font-size: 13px; border: 1px solid var(--border); background: var(--bg); color: var(--text-muted); border-radius: 6px; cursor: pointer; font-family: 'Noto Sans SC', 'Inter', sans-serif; transition: all 0.2s; }
    .lang-switch button:hover { border-color: var(--primary); color: var(--primary); }
    .lang-switch button.active { background: var(--primary); color: #fff; border-color: var(--primary); }
    body[data-lang="zh"] .lang-en { display: none !important; }
    body[data-lang="en"] .lang-zh { display: none !important; }
    .site-footer { margin-top: 48px; padding-top: 24px; border-top: 1px solid var(--border); font-size: 13px; color: var(--text-muted); text-align: center; }
    .site-footer a { color: var(--primary); text-decoration: none; }
    .site-footer a:hover { text-decoration: underline; }
    .mission-block { background-color: #ffffff; background-image: linear-gradient(to bottom, rgba(255,255,255,0.9) 0%, rgba(255,255,255,0.95) 100%), url('images/hero-bg.svg'); background-size: cover; background-position: center; border-radius: 12px; padding: 32px; margin-bottom: 32px; border: 1px solid rgba(13,148,136,0.1); border-left: 4px solid var(--primary); box-shadow: 0 4px 12px rgba(13,148,136,0.05); }
    .mission-block p { margin: 0; font-size: 16px; line-height: 1.7; color: var(--text); }
    .mission-block p + p { margin-top: 14px; }
    
    /* Responsive styles */
    @media (max-width: 900px) {
      .top-header { flex-wrap: wrap; padding: 12px 16px; gap: 10px; }
      .top-header .brand { flex: 1 1 auto; min-width: 0; display: flex; align-items: center; flex-wrap: wrap; gap: 8px; }
      .top-header .slogan { display: inline-block !important; font-size: 12px; padding-left: 10px; border-left: 1px solid var(--border); white-space: nowrap; }
      .top-header .header-right { order: 2; margin-left: auto; }
      .top-header-nav { order: 3; width: 100%; flex: 1 1 100%; justify-content: flex-start; flex-wrap: wrap; gap: 6px; overflow-x: auto; padding-bottom: 4px; -webkit-overflow-scrolling: touch; border-top: 1px solid var(--border); padding-top: 10px; margin-top: 2px; }
      .top-header-nav a { flex-shrink: 0; font-size: 13px; padding: 6px 10px; }
      .page-wrap { flex-direction: column; min-height: auto; }
      .sidebar { width: 100%; height: auto; position: relative; border-right: none; border-bottom: 1px solid #e0e0e0; padding: 16px; }
      .sidebar nav { display: flex; flex-wrap: wrap; gap: 8px; }
      .sidebar nav a { display: inline-flex; padding: 8px 12px; border-radius: 6px; border-left: none; }
      .main { padding: 24px 24px 48px; }
      .mission-block { padding: 20px; margin-bottom: 24px; }
    }
  </style>
</head>
<body data-lang="en" id="insynbio-body">
  <header class="top-header">
    <div class="brand">
      <a href="index.html" style="display: flex; align-items: center; gap: 10px; text-decoration: none;">
        <svg width="32" height="32" viewBox="0 0 32 32" fill="none" xmlns="http://www.w3.org/2000/svg">
          <defs>
            <linearGradient id="logo_grad_2" x1="0" y1="0" x2="32" y2="32" gradientUnits="userSpaceOnUse">
              <stop stop-color="#0d9488" />
              <stop offset="1" stop-color="#2dd4bf" />
            </linearGradient>
          </defs>
          <path d="M7 6L16 18V28" stroke="url(#logo_grad_2)" stroke-width="3" stroke-linecap="round" stroke-linejoin="round"/>
          <path d="M25 6L16 18" stroke="url(#logo_grad_2)" stroke-width="3" stroke-linecap="round" stroke-linejoin="round"/>
          <circle cx="7" cy="6" r="2" fill="#0f766e" />
          <circle cx="25" cy="6" r="2" fill="#0f766e" />
          <circle cx="16" cy="18" r="2" fill="white" stroke="#0d9488" stroke-width="1.5"/>
        </svg>
        <span style="font-family: 'Cormorant Garamond', serif; font-weight: 700; font-size: 26px; color: #1f2937; letter-spacing: -0.02em;">
          In<span style="color: #0d9488;">Syn</span>Bio
        </span>
      </a>
      <span class="slogan lang-en">AI for Life Sciences</span>
      <span class="slogan lang-zh">AI èµ‹èƒ½ç”Ÿå‘½ç§‘å­¦</span>
    </div>
    <nav class="top-header-nav">
      <a href="index.html"><span class="lang-en">Home</span><span class="lang-zh">é¦–é¡µ</span></a>
      <a href="index.html#about"><span class="lang-en">About Us</span><span class="lang-zh">å…³äºæˆ‘ä»¬</span></a>
      <div class="nav-dropdown" tabindex="0">
        <a href="index.html#services"><span class="lang-en">Services</span><span class="lang-zh">æœåŠ¡</span></a>
        <div class="dropdown-menu">
          <a href="InSynBio_Antibody_Developability_Assessment_Page.html">
            <span class="menu-title"><span class="lang-en">Antibody</span><span class="lang-zh">æŠ—ä½“è¯„ä¼°</span></span>
            <span class="menu-desc"><span class="lang-en">Structure-based Development</span><span class="lang-zh">åŸºäºç»“æ„çš„æŠ—ä½“å¼€å‘</span></span>
          </a>
          <a href="#platform">
            <span class="menu-title"><span class="lang-en">CAR-T</span><span class="lang-zh">CAR-T</span></span>
            <span class="menu-desc"><span class="lang-en">Smart CAR-T Design</span><span class="lang-zh">æ™ºæ…§ CAR-T è®¾è®¡</span></span>
          </a>
          <a href="index.html#services">
            <span class="menu-title"><span class="lang-en">Bispecific</span><span class="lang-zh">åŒç‰¹å¼‚æŠ—ä½“</span> <span class="lang-en">(Coming soon)</span><span class="lang-zh">(æ•¬è¯·æœŸå¾…)</span></span>
            <span class="menu-desc"><span class="lang-en">Multispecific Modalities</span><span class="lang-zh">å¤šç‰¹å¼‚æ€§æ¨¡æ€</span></span>
          </a>
        </div>
      </div>
      <a href="#submit" class="cta"><span class="lang-en">Submit Inquiry</span><span class="lang-zh">æäº¤å’¨è¯¢</span></a>
      <a href="#contact"><span class="lang-en">Contact</span><span class="lang-zh">è”ç³»</span></a>
    </nav>
    <div class="header-right">
      <div class="lang-switch">
        <button type="button" class="lang-btn active" data-lang="en">EN</button>
        <button type="button" class="lang-btn" data-lang="zh">ZH</button>
      </div>
    </div>
  </header>
  <div class="page-wrap">
    <aside class="sidebar">
      <h3 class="lang-en">Smart CAR-T</h3>
      <h3 class="lang-zh">æ™ºæ…§ CAR-T</h3>
      <nav>
        <a href="#platform" class="nav-link active">
          <svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><rect x="3" y="3" width="7" height="7"/><rect x="14" y="3" width="7" height="7"/><rect x="3" y="14" width="7" height="7"/><rect x="14" y="14" width="7" height="7"/></svg>
          <span class="lang-en">Platform</span><span class="lang-zh">å¹³å°</span>
        </a>
        <a href="#library" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M4 19.5A2.5 2.5 0 0 1 6.5 17H20"/><path d="M6.5 2H20v20H6.5A2.5 2.5 0 0 1 4 19.5v-15A2.5 2.5 0 0 1 6.5 2z"/></svg><span class="lang-en">Component Library</span><span class="lang-zh">å…ƒä»¶åº“</span></a>
        <a href="#strategy" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M22 12h-4l-3 9L9 3l-3 9H2"/></svg><span class="lang-en">Disease Strategy</span><span class="lang-zh">ç–¾ç—…ç­–ç•¥</span></a>
        <a href="#engineering" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M14.7 6.3a1 1 0 0 0 0 1.4l1.6 1.6a1 1 0 0 0 1.4 0l3.77-3.77a6 6 0 0 1-7.94 7.94l-6.91 6.91a2.12 2.12 0 0 1-3-3l6.91-6.91a6 6 0 0 1 7.94-7.94l-3.76 3.76z"/></svg><span class="lang-en">Engineering</span><span class="lang-zh">å·¥ç¨‹åŒ–æ¨¡å—</span></a>
        <a href="#example" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><polyline points="4 17 10 11 4 5"/><line x1="12" y1="19" x2="20" y2="19"/></svg><span class="lang-en">Case Study</span><span class="lang-zh">è®¾è®¡ç¤ºä¾‹</span></a>
        <a href="#safety" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M12 22s8-4 8-10V5l-8-3-8 3v7c0 6 8 10 8 10z"/></svg><span class="lang-en">Safety & Efficacy</span><span class="lang-zh">å®‰å…¨ä¸æœ‰æ•ˆæ€§</span></a>
        <a href="#full-report" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M14 2H6a2 2 0 0 0-2 2v16a2 2 0 0 0 2 2h12a2 2 0 0 0 2-2V8z"/><polyline points="14 2 14 8 20 8"/><line x1="16" y1="13" x2="8" y2="13"/><line x1="16" y1="17" x2="8" y2="17"/><polyline points="10 9 9 9 8 9"/></svg><span class="lang-en">Full Report</span><span class="lang-zh">å®Œæ•´æŠ¥å‘Š</span></a>
        <a href="#submit" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><line x1="22" y1="2" x2="11" y2="13"/><polygon points="22 2 15 22 11 13 2 9 22 2"/></svg><span class="lang-en">Submit Inquiry</span><span class="lang-zh">æäº¤å’¨è¯¢</span></a>
        <a href="#contact" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M4 4h16c1.1 0 2 .9 2 2v12c0 1.1-.9 2-2 2H4c-1.1 0-2-.9-2-2V6c0-1.1.9-2 2-2z"/><polyline points="22,6 12,13 2,6"/></svg><span class="lang-en">Contact</span><span class="lang-zh">è”ç³»æ–¹å¼</span></a>
      </nav>
    </aside>
    <main class="main">
      <div class="breadcrumb">
        <a href="index.html"><span class="lang-en">Home</span><span class="lang-zh">é¦–é¡µ</span></a><span>/</span><a href="index.html#services"><span class="lang-en">Services</span><span class="lang-zh">æœåŠ¡</span></a><span>/</span><span><span class="lang-en">Smart CAR-T</span><span class="lang-zh">æ™ºæ…§ CAR-T</span></span>
      </div>

      <!-- Hero / Mission (same structure as Antibody page) -->
      <div class="mission-block">
        <p class="lang-en"><strong>Smart CAR-T Design:</strong> AI-driven end-to-end engineering service. From target selection to sequence design and CRO validation. We provide rational design frameworks for Solid Tumors, Hematologic Malignancies, and Autoimmune Diseases.</p>
        <p class="lang-zh"><strong>æ™ºæ…§ CAR-T è®¾è®¡ï¼š</strong>AI é©±åŠ¨çš„ç«¯åˆ°ç«¯å·¥ç¨‹æœåŠ¡ã€‚ä»é¶ç‚¹é€‰æ‹©åˆ°åºåˆ—è®¾è®¡åŠ CRO éªŒè¯ã€‚æˆ‘ä»¬ä¸ºå®ä½“ç˜¤ã€è¡€æ¶²ç˜¤åŠè‡ªèº«å…ç–«ç–¾ç—…æä¾›ç†æ€§è®¾è®¡æ¡†æ¶ã€‚</p>
        <p class="lang-en">Our ACTES platform combines a proprietary library of nearly 200 curated components with antigen knowledge base, smart vector logic, epitopeâ€“hinge matching, and affinity tuning. We support lentiviral, non-viral, and in vivo delivery strategies and offer CRO-ready validation support. <a href="index.html#about">Learn more â†’</a></p>
        <p class="lang-zh">ACTES å¹³å°å°†ä¸“æœ‰è¿‘ 200 ä¸ªç²¾é€‰å…ƒä»¶åº“ä¸æŠ—åŸçŸ¥è¯†åº“ã€æ™ºèƒ½è½½ä½“é€»è¾‘ã€è¡¨ä½â€“é“°é“¾åŒ¹é…åŠäº²å’ŒåŠ›è°ƒä¼˜ç›¸ç»“åˆã€‚æˆ‘ä»¬æ”¯æŒæ…¢ç—…æ¯’ã€éç—…æ¯’åŠä½“å†…é€’é€ç­–ç•¥ï¼Œå¹¶æä¾›å¯å¯¹æ¥ CRO çš„éªŒè¯æ”¯æŒã€‚<a href="index.html#about">äº†è§£æ›´å¤š â†’</a></p>
      </div>

      <h1><span class="lang-en">Smart CAR-T Design</span><span class="lang-zh">æ™ºæ…§ CAR-T è®¾è®¡</span></h1>
      <p class="subtitle lang-en">AI-Driven End-to-End Engineering: From Target to Sequence, From Sequence to System.</p>
      <p class="subtitle lang-zh">AI é©±åŠ¨çš„ç«¯åˆ°ç«¯å·¥ç¨‹ï¼šä»é¶ç‚¹åˆ°åºåˆ—ï¼Œä»åºåˆ—åˆ°ç³»ç»Ÿã€‚</p>
      <p class="disclaimer lang-en">Disclaimer: InSynBio in silico analyses are for reference only and do not replace final wet-lab validation. Experimental confirmation is required.</p>
      <p class="disclaimer lang-zh">å…è´£å£°æ˜ï¼šInSynBio çš„ in silico åˆ†æä»…ä¾›å‚è€ƒï¼Œä¸èƒ½æ›¿ä»£æœ€ç»ˆæ¹¿å®éªŒéªŒè¯ã€‚éœ€è¿›è¡Œå®éªŒç¡®è®¤ã€‚</p>

      <h2 id="platform"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><rect x="3" y="3" width="7" height="7"/><rect x="14" y="3" width="7" height="7"/><rect x="3" y="14" width="7" height="7"/><rect x="14" y="14" width="7" height="7"/></svg></span><span class="lang-en">AI-Native Design Platform</span><span class="lang-zh">AI åŸç”Ÿè®¾è®¡å¹³å°</span></h2>
      <p class="lang-en">Our ACTES platform leverages a proprietary library of <strong>nearly 200 curated components</strong> across 10 categories. We don't just assemble; we match.</p>
      <p class="lang-zh">ACTES å¹³å°åŸºäºåŒ…å« 10 å¤§ç±»ã€<strong>è¿‘ 200 ä¸ªç²¾é€‰å…ƒä»¶</strong>çš„ä¸“æœ‰åº“ã€‚æˆ‘ä»¬ä¸ä»…ä»…æ˜¯ç»„è£…ï¼Œè€Œæ˜¯ç²¾å‡†åŒ¹é…ã€‚</p>
      <ul class="lang-en">
        <li><strong>Antigen Knowledge Base</strong> â€” A continuously updated database of <strong>common epitopes</strong>, <strong>antigen density</strong> thresholds, <strong>heterogeneity</strong> profiles, <strong>disease context</strong> (solid vs. hematologic vs. autoimmune), and <strong>specificity</strong> considerations (e.g. on-target off-tumor risk) to guide precise design.</li>
        <li><strong>Smart Vector Logic</strong> â€” Algorithmic selection between <strong>Lentiviral</strong> (Standard), <strong>Non-Viral/Transposon</strong> (Large Payload), and <strong>In Vivo LNP</strong> (Accessibility) based on clinical needs.</li>
        <li><strong>Epitope-Hinge Matching</strong> â€” We measure epitope-to-membrane distance using <strong>AlphaFold2</strong> to select the precise Hinge length (Short/Medium/Long).</li>
        <li><strong>Kinetic Engineering</strong> â€” We tune Binder affinity (Kd) and off-rates (koff) via computational mutagenesis. We increase affinity for low-density targets, but tune it down for targets like HER2 to spare normal tissues, while ensuring fast dissociation to prevent exhaustion.</li>
        <li><strong>Density-Signaling Logic</strong> â€” We analyze antigen density to select the optimal Transmembrane (CD8Î± vs CD28) and Signaling domains (4-1BB vs CD28).</li>
      </ul>
      <ul class="lang-zh">
        <li><strong>æŠ—åŸçŸ¥è¯†åº“</strong> â€” ç»´æŠ¤æŒç»­æ›´æ–°çš„æ•°æ®åº“ï¼ŒåŒ…å«<strong>å¸¸è§è¡¨ä½</strong>ã€<strong>æŠ—åŸå¯†åº¦</strong>é˜ˆå€¼ã€<strong>å¼‚è´¨æ€§</strong>å›¾è°±ã€<strong>ç–¾ç—…è¯­å¢ƒ</strong>ï¼ˆå®ä½“ç˜¤/è¡€æ¶²ç˜¤/è‡ªèº«å…ç–«ï¼‰åŠ<strong>ç‰¹å¼‚æ€§</strong>è€ƒé‡ï¼ˆå¦‚ on-target off-tumor é£é™©ï¼‰ï¼ŒæŒ‡å¯¼ç²¾å‡†è®¾è®¡ã€‚</li>
        <li><strong>æ™ºèƒ½è½½ä½“é€»è¾‘</strong> â€” æ ¹æ®ä¸´åºŠéœ€æ±‚ç®—æ³•åŒ–é€‰æ‹©ï¼š<strong>æ…¢ç—…æ¯’</strong> (æ ‡å‡†)ã€<strong>éç—…æ¯’/è½¬åº§å­</strong> (å¤§è½½è·) æˆ– <strong>ä½“å†… LNP</strong> (å¯åŠæ€§)ã€‚</li>
        <li><strong>è¡¨ä½-é“°é“¾åŒ¹é…</strong> â€” åˆ©ç”¨ <strong>AlphaFold2</strong> æµ‹é‡è¡¨ä½åˆ°ç»†èƒè†œçš„è·ç¦»ï¼Œç²¾å‡†é€‰æ‹©é“°é“¾é•¿åº¦ï¼ˆçŸ­/ä¸­/é•¿ï¼‰ã€‚</li>
        <li><strong>åŠ¨åŠ›å­¦å·¥ç¨‹</strong> â€” é€šè¿‡è®¡ç®—çªå˜ä¼˜åŒ– Binder äº²å’ŒåŠ› (Kd) ä¸è§£ç¦»é€Ÿç‡ (koff)ã€‚é’ˆå¯¹ä½å¯†åº¦é¶ç‚¹æå‡äº²å’ŒåŠ›ï¼›é’ˆå¯¹ HER2 ç­‰é¶ç‚¹ä¸‹è°ƒäº²å’ŒåŠ›ä»¥ä¿æŠ¤æ­£å¸¸ç»„ç»‡ï¼›åŒæ—¶ç¡®ä¿å¿«é€Ÿè§£ç¦»ä»¥é˜²æ­¢è€—ç«­ã€‚</li>
        <li><strong>å¯†åº¦-ä¿¡å·é€»è¾‘</strong> â€” åˆ†ææŠ—åŸå¯†åº¦ï¼Œé€‰æ‹©æœ€ä¼˜çš„è·¨è†œåŸŸï¼ˆCD8Î± vs CD28ï¼‰ä¸ä¿¡å·åŸŸï¼ˆ4-1BB vs CD28ï¼‰ã€‚</li>
      </ul>

      <h2 id="library"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M4 19.5A2.5 2.5 0 0 1 6.5 17H20"/><path d="M6.5 2H20v20H6.5A2.5 2.5 0 0 1 4 19.5v-15A2.5 2.5 0 0 1 6.5 2z"/></svg></span><span class="lang-en">Proprietary Component Library</span><span class="lang-zh">ä¸“æœ‰å…ƒä»¶åº“</span></h2>
      <p class="lang-en">Our ACTES platform houses a continuously updated library of <strong>nearly 200 curated components</strong> across 10 major categories, spanning clinical standards to frontier modalities.</p>
      <p class="lang-zh">ACTES å¹³å°æ‹¥æœ‰ä¸€ä¸ªæŒç»­æ›´æ–°çš„<strong>è¿‘ 200 ä¸ªç²¾é€‰å…ƒä»¶</strong>åº“ï¼Œæ¶µç›– 10 å¤§ç±»ï¼Œä»ä¸´åºŠæ ‡å‡†åˆ°å‰æ²¿æ¨¡æ€ã€‚</p>
      
      <div class="table-wrap">
      <table style="width:100%; border-collapse: collapse; font-size: 13px;">
        <thead>
          <tr>
            <th style="width: 11%;"><span class="lang-en">Category</span><span class="lang-zh">ç±»åˆ«</span></th>
            <th style="width: 16%;"><span class="lang-en">Function</span><span class="lang-zh">åŠŸèƒ½</span></th>
            <th style="width: 32%;"><span class="lang-en">Clinical Standards (Validated)</span><span class="lang-zh">ä¸´åºŠæ ‡å‡† (å·²éªŒè¯)</span></th>
            <th style="width: 41%; min-width: 200px;"><span class="lang-en">Frontier Modalities (Emerging)</span><span class="lang-zh">å‰æ²¿æ¨¡æ€ (æ–°å…´)</span></th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><span class="lang-en"><strong>Binders</strong></span><span class="lang-zh"><strong>ç»“åˆåŸŸ</strong></span></td>
            <td><span class="lang-en">Target recognition</span><span class="lang-zh">é¶å‘è¯†åˆ«</span></td>
            <td><span class="lang-en">scFv (FMC63, Trastuzumab, 14G2a, SS1, m971, 4D5, 225), Humanized scFv, Fab Fragments</span><span class="lang-zh">scFv (FMC63, Trastuzumab, 14G2a, SS1, m971, 4D5, 225)ã€äººæºåŒ– scFvã€Fab ç‰‡æ®µ</span></td>
            <td><span class="lang-en">VHH/Nanobody (Solid Tumor), TCR-mimic (WT1, KRAS, NY-ESO-1, MAGE-A4), Centyrins, DARPins, Ligand-based (IL-13, APRIL), Computational Mask Design (FTO-Focused), Peptide Binders</span><span class="lang-zh">VHH/çº³ç±³æŠ—ä½“ (å®ä½“ç˜¤)ã€TCR æ¨¡æ‹Ÿ (WT1, KRAS, NY-ESO-1, MAGE-A4)ã€Centyrinsã€DARPinsã€é…ä½“ç±» (IL-13, APRIL)ã€è®¡ç®— Mask è®¾è®¡ (FTO)ã€å¤šè‚½ Binder</span></td>
          </tr>
          <tr>
            <td><span class="lang-en"><strong>Hinge</strong></span><span class="lang-zh"><strong>é“°é“¾åŸŸ</strong></span></td>
            <td><span class="lang-en">Epitope distance matching</span><span class="lang-zh">è¡¨ä½è·ç¦»åŒ¹é…</span></td>
            <td><span class="lang-en">CD8Î± Short (45aa), IgG4 Long (228aa), CD28 Medium, IgG1 Hinge</span><span class="lang-zh">CD8Î± çŸ­ (45aa)ã€IgG4 é•¿ (228aa)ã€CD28 ä¸­ã€IgG1 é“°é“¾</span></td>
            <td><span class="lang-en">IgG4-SPLE (Fc-Null/S228P), Auto-Hinge (AI-Matched), IgD Hinge (Protease Resistant), CD8Î±-Long (119aa), Synthetic Flexible Linkers, Rigid EAAAK Linkers</span><span class="lang-zh">IgG4-SPLE (Fc ç©º/S228P)ã€Auto-Hinge (AI åŒ¹é…)ã€IgD é“°é“¾ (æŠ—è›‹ç™½é…¶)ã€CD8Î±-é•¿ (119aa)ã€åˆæˆæŸ”æ€§è¿æ¥å­ã€åˆšæ€§ EAAAK è¿æ¥å­</span></td>
          </tr>
          <tr>
            <td><span class="lang-en"><strong>Transmembrane</strong></span><span class="lang-zh"><strong>è·¨è†œåŸŸ</strong></span></td>
            <td><span class="lang-en">Anchoring & signaling threshold</span><span class="lang-zh">è†œé”šå®šä¸ä¿¡å·é˜ˆå€¼</span></td>
            <td><span class="lang-en">CD8Î± TM (Low tonic), CD28 TM (Lipid raft), CD4 TM</span><span class="lang-zh">CD8Î± è·¨è†œ (ä½åŸºåº•)ã€CD28 è·¨è†œ (è„‚ç­)ã€CD4 è·¨è†œ</span></td>
            <td><span class="lang-en">NKG2D TM (NK Optimization), DAP10 TM, DAP12 TM, ICOS TM, OX40 TM, In Vivo Optimized TM (LNP-compatible)</span><span class="lang-zh">NKG2D è·¨è†œ (NK ä¼˜åŒ–)ã€DAP10/DAP12/ICOS/OX40 è·¨è†œã€ä½“å†…ä¼˜åŒ–è·¨è†œ (LNP å…¼å®¹)</span></td>
          </tr>
          <tr>
            <td><span class="lang-en"><strong>Co-stimulatory</strong></span><span class="lang-zh"><strong>å…±åˆºæ¿€åŸŸ</strong></span></td>
            <td><span class="lang-en">Metabolism & Persistence</span><span class="lang-zh">ä»£è°¢ä¸æŒä¹…æ€§</span></td>
            <td><span class="lang-en">4-1BB (Mitochondrial), CD28 (Glycolytic)</span><span class="lang-zh">4-1BB (çº¿ç²’ä½“)ã€CD28 (ç³–é…µè§£)</span></td>
            <td><span class="lang-en">OX40 (CD134), ICOS (Th17/Th1), 2B4 (CD244), DAP10, CD27, GITR, HVEM, CD40, MyD88, TLR2, 4-1BBL (Self-Driving)</span><span class="lang-zh">OX40ã€ICOSã€2B4ã€DAP10ã€CD27ã€GITRã€HVEMã€CD40ã€MyD88ã€TLR2ã€4-1BBL (è‡ªé©±åŠ¨)</span></td>
          </tr>
          <tr>
            <td><span class="lang-en"><strong>Activation</strong></span><span class="lang-zh"><strong>æ¿€æ´»åŸŸ</strong></span></td>
            <td><span class="lang-en">Killing signal</span><span class="lang-zh">æ€ä¼¤ä¿¡å·</span></td>
            <td><span class="lang-en">CD3Î¶ (3x ITAM)</span><span class="lang-zh">CD3Î¶ (3Ã— ITAM)</span></td>
            <td><span class="lang-en">DAP12 (CAR-NK/Macrophage), FcR-Î³ (Phagocytosis), CD3Îµ (Recruitment), ZAP70 recruitment motifs, 1XX (Calibrated ITAMs)</span><span class="lang-zh">DAP12 (CAR-NK/å·¨å™¬ç»†èƒ)ã€FcR-Î³ (åå™¬)ã€CD3Îµ (æ‹›å‹Ÿ)ã€ZAP70 æ‹›å‹Ÿ motifã€1XX (æ ¡å‡† ITAM)</span></td>
          </tr>
          <tr>
            <td><span class="lang-en"><strong>Armored Payloads</strong></span><span class="lang-zh"><strong>é“ ç”²è½½è·</strong></span></td>
            <td><span class="lang-en">TME remodeling & Resistance</span><span class="lang-zh">TME é‡å¡‘ä¸æŠµæŠ—</span></td>
            <td><span class="lang-en">Secreted IL-12 (TRUCK), Constitutive IL-15</span><span class="lang-zh">åˆ†æ³Œå‹ IL-12 (TRUCK)ã€ç»„æˆå‹ IL-15</span></td>
            <td><span class="lang-en">TGFB_DNR (Anti-Suppression), Membrane_IL15/IL-21, GPX4_Enhanced (Anti-Ferroptosis), IL-7/CCL19 (7x19), c-JUN, HPSE (Heparanase), scFv-PD1 blocker, BiTE secretion</span><span class="lang-zh">TGFB_DNR (æŠ—æŠ‘åˆ¶)ã€è†œé”šå®š IL-15/IL-21ã€GPX4_Enhanced (æŠ—é“æ­»äº¡)ã€IL-7/CCL19 (7x19)ã€c-JUNã€HPSEã€scFv-PD1 é˜»æ–­ã€BiTE åˆ†æ³Œ</span></td>
          </tr>
          <tr>
            <td><span class="lang-en"><strong>Safety Switches</strong></span><span class="lang-zh"><strong>å®‰å…¨å¼€å…³</strong></span></td>
            <td><span class="lang-en">Controllable elimination</span><span class="lang-zh">å¯æ§æ¸…é™¤</span></td>
            <td><span class="lang-en">tEGFR (Cetuximab), CD20 Mimotope (Rituximab)</span><span class="lang-zh">tEGFR (è¥¿å¦¥æ˜”å•æŠ—æ¸…é™¤)ã€CD20 æ‹Ÿæ€è¡¨ä½ (åˆ©å¦¥æ˜”å•æŠ—æ¸…é™¤)</span></td>
            <td><span class="lang-en">iCasp9 (Small Molecule, >95%), RQR8 (Dual Tag), Rapamycin-ON, Lenalidomide-ON, HSV-TK, TMPD-inducible</span><span class="lang-zh">iCasp9 (å°åˆ†å­, >95%)ã€RQR8 (åŒæ ‡ç­¾)ã€Rapamycin-ONã€Lenalidomide-ONã€HSV-TKã€TMPD è¯±å¯¼</span></td>
          </tr>
          <tr>
            <td><span class="lang-en"><strong>Logic Gates</strong></span><span class="lang-zh"><strong>é€»è¾‘é—¨æ§</strong></span></td>
            <td><span class="lang-en">Specificity control (AND/NOT)</span><span class="lang-zh">ç‰¹å¼‚æ€§æ§åˆ¶</span></td>
            <td><span class="lang-en">Tandem CAR (OR Gate)</span><span class="lang-zh">ä¸²è” CAR (OR é—¨)</span></td>
            <td><span class="lang-en">SynNotch (AND Gate), iCAR (NOT Gate/PD-1/CTLA-4), Split CAR (Dimerization), LOCKR (Protein Switch), CLIP-CAR, Universal CAR (BBIR)</span><span class="lang-zh">SynNotch (AND é—¨)ã€iCAR (NOT é—¨/PD-1/CTLA-4)ã€Split CAR (äºŒèšåŒ–)ã€LOCKRã€CLIP-CARã€é€šç”¨ CAR (BBIR)</span></td>
          </tr>
          <tr>
            <td><span class="lang-en"><strong>Regulatory</strong></span><span class="lang-zh"><strong>è°ƒæ§å…ƒä»¶</strong></span></td>
            <td><span class="lang-en">Expression control</span><span class="lang-zh">è¡¨è¾¾æ§åˆ¶</span></td>
            <td><span class="lang-en">EF1Î± Promoter, PGK Promoter, WPRE</span><span class="lang-zh">EF1Î± å¯åŠ¨å­ã€PGK å¯åŠ¨å­ã€WPRE</span></td>
            <td><span class="lang-en">NFAT_Response (Inducible), UCOE (Anti-Silencing), Tet-On/Tet-Off, SFFV, CMV, SV40, EFS (Compact), JeT promoter</span><span class="lang-zh">NFAT_Response (è¯±å¯¼å‹)ã€UCOE (æŠ—æ²‰é»˜)ã€Tet-On/Tet-Offã€SFFVã€CMVã€SV40ã€EFS (ç´§å‡‘)ã€JeT å¯åŠ¨å­</span></td>
          </tr>
          <tr>
            <td><span class="lang-en"><strong>Leaders & Linkers</strong></span><span class="lang-zh"><strong>ä¿¡å·è‚½ä¸è¿æ¥å­</strong></span></td>
            <td><span class="lang-en">Secretion & Flexibility</span><span class="lang-zh">åˆ†æ³Œä¸æŸ”æ€§</span></td>
            <td><span class="lang-en">CD8Î± SP, GM-CSF SP, G4S (Flexible)</span><span class="lang-zh">CD8Î± ä¿¡å·è‚½ã€GM-CSF ä¿¡å·è‚½ã€G4S (æŸ”æ€§)</span></td>
            <td><span class="lang-en">IL-2 SP (Secretion), Gaussia SP, EAAAK3 (Rigid), Whitlow Linker, 218 Linker, XTEN, Furin-P2A/T2A/E2A/F2A</span><span class="lang-zh">IL-2 ä¿¡å·è‚½ã€Gaussia ä¿¡å·è‚½ã€EAAAK3 (åˆšæ€§)ã€Whitlow/218 è¿æ¥å­ã€XTENã€Furin-P2A/T2A/E2A/F2A</span></td>
          </tr>
        </tbody>
      </table>
      </div>

      <h2 id="strategy"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M22 12h-4l-3 9L9 3l-3 9H2"/></svg></span><span class="lang-en">Therapeutic Architecture Matrix</span><span class="lang-zh">æ²»ç–—æ¶æ„çŸ©é˜µ</span></h2>
      <p class="lang-en">Our AI engine applies deep biological logic to select the optimal architecture. We don't just assemble parts; we design <strong>systems</strong> to overcome specific disease barriers.</p>
      <p class="lang-zh">æˆ‘ä»¬çš„ AI å¼•æ“åº”ç”¨æ·±åº¦ç”Ÿç‰©å­¦é€»è¾‘æ¥é€‰æ‹©æœ€ä½³æ¶æ„ã€‚æˆ‘ä»¬ä¸åªæ˜¯ç»„è£…å…ƒä»¶ï¼Œè€Œæ˜¯è®¾è®¡<strong>ç³»ç»Ÿ</strong>ä»¥å…‹æœç‰¹å®šçš„ç–¾ç—…éšœç¢ã€‚</p>
      <div class="table-wrap">
      <table style="width:100%; border-collapse: collapse;">
        <thead>
          <tr>
            <th><span class="lang-en">Disease Context</span><span class="lang-zh">ç–¾ç—…è¯­å¢ƒ</span></th>
            <th><span class="lang-en">Critical Barriers</span><span class="lang-zh">æ ¸å¿ƒå£å’</span></th>
            <th><span class="lang-en">Advanced Architectural Solution</span><span class="lang-zh">é«˜çº§æ¶æ„æ–¹æ¡ˆ</span></th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong><span class="lang-en">Solid Tumors (e.g., HCC, Gastric)</span><span class="lang-zh">å®ä½“ç˜¤ (å¦‚è‚ç™Œã€èƒƒç™Œ)</span></strong></td>
            <td><span class="lang-en"><strong>Physical Exclusion</strong> (ECM), <strong>Immunosuppression</strong> (TGF-Î²) & <strong>On-Target Off-Tumor</strong></span><span class="lang-zh"><strong>ç‰©ç†æ’æ–¥</strong> (ECM)ã€<strong>å…ç–«æŠ‘åˆ¶</strong> (TGF-Î²) ä¸ <strong>è„±é¶æ¯’æ€§ (on-target off-tumor)</strong></span></td>
            <td><span class="lang-en"><strong>Matrix-Degrading Synergy:</strong> CAR-M to degrade ECM + CAR-T armored with <strong>TGFB_DNR</strong>. <strong>Affinity Tuning</strong> (lower Kd on normal-tissue antigens) and <strong>Logic-Gated</strong> recognition to spare healthy tissue.</span><span class="lang-zh"><strong>åŸºè´¨é™è§£ååŒï¼š</strong> CAR-M é™è§£ ECM + è£…å¤‡ <strong>TGFB_DNR</strong> çš„ CAR-Tã€‚<strong>äº²å’ŒåŠ›è°ƒä¼˜</strong> ä¸ <strong>é€»è¾‘é—¨æ§</strong> è¯†åˆ«ä»¥ä¿æŠ¤æ­£å¸¸ç»„ç»‡ã€‚</span></td>
          </tr>
          <tr>
            <td><strong><span class="lang-en">Hematologic / Liquid Tumors (e.g., B-ALL, LBCL)</span><span class="lang-zh">è¡€æ¶²ç˜¤ / æ¶²ä½“ç˜¤ (å¦‚ B-ALLã€LBCL)</span></strong></td>
            <td><span class="lang-en"><strong>Cytokine Storm (CRS)</strong> & <strong>B-cell Aplasia</strong></span><span class="lang-zh"><strong>ç»†èƒå› å­é£æš´ (CRS)</strong> ä¸ <strong>B ç»†èƒå†ç”Ÿéšœç¢</strong></span></td>
            <td><span class="lang-en"><strong>4-1BB-Dominant</strong> (reduced CRS vs CD28), <strong>Safety Switches</strong> (tEGFR, iCasp9) for controllable elimination, <strong>Tuned Affinity</strong> and dose to balance efficacy and toxicity.</span><span class="lang-zh"><strong>4-1BB ä¸»å¯¼</strong> (è¾ƒ CD28 é™ä½ CRS)ã€<strong>å®‰å…¨å¼€å…³</strong> (tEGFR, iCasp9) å¯æ§æ¸…é™¤ã€<strong>äº²å’ŒåŠ›ä¸å‰‚é‡è°ƒä¼˜</strong> å¹³è¡¡ç–—æ•ˆä¸æ¯’æ€§ã€‚</span></td>
          </tr>
          <tr>
            <td><strong><span class="lang-en">AML / Myeloid Malignancies</span><span class="lang-zh">AML / é«“ç³»æ¶æ€§è‚¿ç˜¤</span></strong></td>
            <td><span class="lang-en"><strong>Shared Toxicity</strong> (Healthy marrow depletion) & <strong>Relapse</strong></span><span class="lang-zh"><strong>å…±è¡¨è¾¾æ¯’æ€§</strong> (å¥åº·éª¨é«“è€—ç«­) & <strong>å¤å‘</strong></span></td>
            <td><span class="lang-en"><strong>Transient "Hit-and-Run":</strong> <strong>mRNA-LNP In Vivo CAR</strong> for temporary clearance without permanent aplasia, or <strong>Logic-Gated (NOT)</strong> circuits.</span><span class="lang-zh"><strong>ç¬æ—¶â€œæ‰“äº†å°±è·‘â€ç­–ç•¥ï¼š</strong> <strong>mRNA-LNP ä½“å†… CAR</strong> å®ç°æš‚æ—¶æ¸…é™¤è€Œæ— æ°¸ä¹…å†ç”Ÿéšœç¢ï¼Œæˆ–é‡‡ç”¨ <strong>é€»è¾‘é—¨æ§ (NOT)</strong> ç”µè·¯ã€‚</span></td>
          </tr>
          <tr>
            <td><strong><span class="lang-en">Autoimmune (SLE, Lupus)</span><span class="lang-zh">è‡ªèº«å…ç–« (SLE, çº¢æ–‘ç‹¼ç–®)</span></strong></td>
            <td><span class="lang-en"><strong>Systemic Safety</strong> & <strong>B-cell Aplasia</strong> risks</span><span class="lang-zh"><strong>å…¨èº«å®‰å…¨æ€§</strong> & <strong>B ç»†èƒå†ç”Ÿéšœç¢</strong> é£é™©</span></td>
            <td><span class="lang-en"><strong>Immune Reset:</strong> <strong>CD8-Sparing CAR-Treg</strong> to induce tolerance, or <strong>Short-Lived mRNA CAR</strong> to deplete B-cells once, allowing immune reboot.</span><span class="lang-zh"><strong>å…ç–«é‡ç½®ï¼š</strong> <strong>CD8-Sparing CAR-Treg</strong> è¯±å¯¼è€å—ï¼Œæˆ– <strong>çŸ­æ•ˆ mRNA CAR</strong> å•æ¬¡æ¸…é™¤ B ç»†èƒï¼Œå…è®¸å…ç–«ç³»ç»Ÿé‡å¯ã€‚</span></td>
          </tr>
          <tr>
            <td><strong><span class="lang-en">CNS / Glioblastoma</span><span class="lang-zh">ä¸­æ¢ç¥ç» / èƒ¶è´¨æ¯ç»†èƒç˜¤</span></strong></td>
            <td><span class="lang-en"><strong>Blood-Brain Barrier</strong> & <strong>Neurotoxicity (ICANS)</strong></span><span class="lang-zh"><strong>è¡€è„‘å±éšœ</strong> & <strong>ç¥ç»æ¯’æ€§ (ICANS)</strong></span></td>
            <td><span class="lang-en"><strong>Regional Precision:</strong> <strong>Intracavitary Delivery</strong> (ICV) bypasses BBB. <strong>Hinge/TM Optimization</strong> minimizes tonic signaling to reduce ICANS risk.</span><span class="lang-zh"><strong>åŒºåŸŸç²¾å‡†é€’é€ï¼š</strong> <strong>è…”å†…é€’é€</strong> (ICV) ç»•è¿‡è¡€è„‘å±éšœã€‚<strong>é“°é“¾/è·¨è†œä¼˜åŒ–</strong> æœ€å°åŒ–åŸºåº•ä¿¡å·ä»¥é™ä½ ICANS é£é™©ã€‚</span></td>
          </tr>
        </tbody>
      </table>
      </div>

      <h2 id="engineering"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M14.7 6.3a1 1 0 0 0 0 1.4l1.6 1.6a1 1 0 0 0 1.4 0l3.77-3.77a6 6 0 0 1-7.94 7.94l-6.91 6.91a2.12 2.12 0 0 1-3-3l6.91-6.91a6 6 0 0 1 7.94-7.94l-3.76 3.76z"/></svg></span><span class="lang-en">Engineering Modules</span><span class="lang-zh">å·¥ç¨‹åŒ–æ¨¡å—</span></h2>
      <p class="lang-en">We assemble the optimal CAR construct using a validated library of functional domains.</p>
      <p class="lang-zh">æˆ‘ä»¬ä½¿ç”¨ç»è¿‡éªŒè¯çš„åŠŸèƒ½åŸŸåº“ç»„è£…æœ€ä¼˜ CAR æ„å»ºä½“ã€‚</p>
      <ul class="lang-en">
        <li><strong>Advanced Binders</strong> â€” <strong>De Novo Mask Design</strong> (Computational FTO), <strong>Logic-Gated</strong> recognition, and <strong>Multi-specifics</strong> (BiTE/TriTE secretion).</li>
        <li><strong>Next-Gen Signaling</strong> â€” <strong>JAK-STAT</strong> (IL-2RÎ²) integration (5th Gen), <strong>BATF3-programming</strong> for stemness, and <strong>Synthetic Costimulation</strong> (e.g., 4-1BBL/CD40L).</li>
        <li><strong>In Vivo Delivery</strong> â€” <strong>LNP-optimized mRNA</strong> (Transient/Safe), <strong>Viral-Like Particles (VLP)</strong> (Targeted), and <strong>AAV</strong> (Donor Template) vectors.</li>
        <li><strong>Allogeneic Engineering</strong> â€” <strong>CRISPR/Cas9</strong> gene editing (TRAC/B2M KO) for off-the-shelf universal CAR-T, mitigating GvHD and rejection.</li>
        <li><strong>Armoring (Payloads)</strong> â€” <strong>TGFB_DNR</strong> (Anti-suppression), <strong>Membrane_IL15</strong> (Persistence), <strong>GPX4</strong> (Anti-ferroptosis), <strong>Secreted IL-12</strong> (TRUCK).</li>
        <li><strong>Affinity Tuning</strong> â€” Computational mutagenesis to tune Kd (e.g., lowering affinity for HER2 to spare normal tissue) and k_off (preventing exhaustion).</li>
        <li><strong>Vector & Capacity</strong> â€” <strong>Compact VHH</strong> designs to save payload space; <strong>PiggyBac / Sleeping Beauty Transposon</strong> support for ultra-large constructs (>10kb) surpassing lentiviral limits.</li>
      </ul>
      <ul class="lang-zh">
        <li><strong>é«˜çº§ç»“åˆåŸŸ (Advanced Binders)</strong> â€” <strong>De Novo å±è”½è®¾è®¡</strong> (è®¡ç®— FTO) æå‡ç‰¹å¼‚æ€§ã€<strong>é€»è¾‘é—¨æ§</strong>è¯†åˆ«åŠ<strong>å¤šç‰¹å¼‚æ€§</strong> (BiTE/TriTE åˆ†æ³Œ) è®¾è®¡ã€‚</li>
        <li><strong>ä¸‹ä¸€ä»£ä¿¡å· (Next-Gen Signaling)</strong> â€” é›†æˆ <strong>JAK-STAT</strong> (IL-2RÎ²) é€šè·¯ (ç¬¬äº”ä»£ CAR)ã€<strong>BATF3 é‡ç¼–ç¨‹</strong>ç»´æŒå¹²æ€§åŠ<strong>åˆæˆå…±åˆºæ¿€</strong> (å¦‚ 4-1BBL/CD40L)ã€‚</li>
        <li><strong>ä½“å†…é€’é€ (In Vivo Delivery)</strong> â€” <strong>LNP ä¼˜åŒ– mRNA</strong> (ç¬æ—¶/å®‰å…¨)ã€<strong>ç—…æ¯’æ ·é¢—ç²’ (VLP)</strong> (é¶å‘é€’é€) åŠ <strong>AAV</strong> (ä¾›ä½“æ¨¡æ¿) è½½ä½“ã€‚</li>
        <li><strong>å¼‚ä½“å·¥ç¨‹ (Allogeneic Engineering)</strong> â€” <strong>CRISPR/Cas9</strong> åŸºå› ç¼–è¾‘ (TRAC/B2M æ•²é™¤) æ‰“é€ é€šç”¨å‹ CAR-Tï¼Œæ¶ˆé™¤ GvHD ä¸æ’æ–¥ååº”ã€‚</li>
        <li><strong>é“ ç”² (Armoring)</strong> â€” <strong>TGFB_DNR</strong> (æŠ—æŠ‘åˆ¶), <strong>Membrane_IL15</strong> (æŒä¹…æ€§), <strong>GPX4</strong> (æŠ—é“æ­»äº¡), <strong>åˆ†æ³Œå‹ IL-12</strong> (TRUCK)ã€‚</li>
        <li><strong>äº²å’ŒåŠ›ä¼˜åŒ– (Affinity Tuning)</strong> â€” æä¾› Kd/koff å¾®è°ƒçš„è®¡ç®—çªå˜æœåŠ¡ï¼ˆå¦‚é’ˆå¯¹ HER2 ä¸‹è°ƒäº²å’ŒåŠ›ä»¥ä¿æŠ¤æ­£å¸¸ç»„ç»‡ï¼Œæˆ–è°ƒæ•´è§£ç¦»é€Ÿç‡é˜²æ­¢è€—ç«­ï¼‰ã€‚</li>
        <li><strong>è½½ä½“ä¸å®¹é‡ (Vector & Capacity)</strong> â€” <strong>ç´§å‡‘å‹ VHH</strong> è®¾è®¡èŠ‚çœè½½è·ç©ºé—´ï¼›æ”¯æŒ <strong>PiggyBac / Sleeping Beauty è½¬åº§å­</strong> ç³»ç»Ÿï¼Œçªç ´æ…¢ç—…æ¯’é™åˆ¶ï¼Œæ‰¿è½½è¶…å¤§æ„å»ºä½“ (>10kb)ã€‚</li>
      </ul>

      <h2 id="example"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><polyline points="4 17 10 11 4 5"/><line x1="12" y1="19" x2="20" y2="19"/></svg></span><span class="lang-en">Design Example: GPC3 CAR-T Logic Trace</span><span class="lang-zh">è®¾è®¡ç¤ºä¾‹ï¼šGPC3 CAR-T æ™ºæ…§æ¨æ¼”</span></h2>
      <p class="lang-en">The ACTES engine doesn't just pick parts; it reasons through the biology. Here is the deduction process for a Hepatocellular Carcinoma (HCC) project.</p>
      <p class="lang-zh">ACTES å¼•æ“ä¸ä»…æ˜¯é€‰æ‹©å…ƒä»¶ï¼Œæ›´æ˜¯åœ¨è¿›è¡Œç”Ÿç‰©å­¦æ¨ç†ã€‚ä»¥ä¸‹æ˜¯é’ˆå¯¹è‚ç»†èƒç™Œï¼ˆHCCï¼‰é¡¹ç›®çš„é€»è¾‘æ¨æ¼”è¿‡ç¨‹ã€‚</p>
      
      <div class="logic-box" style="background: #f8fafc; border: 1px solid #e2e8f0; border-radius: 8px; padding: 24px; font-family: 'Inter', sans-serif;">
        <div style="border-bottom: 1px solid #e2e8f0; padding-bottom: 12px; margin-bottom: 16px;">
            <strong style="color: var(--primary); font-size: 14px; text-transform: uppercase;">Input Parameters</strong><br>
            <span style="font-family: monospace; color: var(--text-muted);">Target: GPC3 | Indication: Solid Tumor (HCC) | Delivery: Lentiviral</span>
        </div>

        <div class="step" style="margin-bottom: 16px;">
            <strong style="color: #0f172a;">Step 1: Structural Topology Analysis</strong><br>
            <span style="color: var(--text-muted); font-size: 14px;">â€¢ Query: Where is the epitope located on GPC3?</span><br>
            <span style="color: var(--primary); font-weight: 500; font-size: 14px;">â†’ Result: Membrane Proximal (&lt; 5nm distance).</span><br>
            <div style="background: rgba(13,148,136,0.1); padding: 8px 12px; border-radius: 6px; margin-top: 6px; font-size: 13px; color: var(--primary-dark);">
                <strong>ğŸ’¡ AI Decision:</strong> Enforce <strong>CD8Î± Short Hinge</strong>. <br>
                <em>Reasoning: A Long Hinge (e.g., IgG4) would push the CAR too far from the target, preventing effective immunological synapse formation.</em>
            </div>
        </div>

        <div class="step" style="margin-bottom: 16px;">
            <strong style="color: #0f172a;">Step 2: TME Counter-Strategy</strong><br>
            <span style="color: var(--text-muted); font-size: 14px;">â€¢ Query: What are the suppression factors in HCC?</span><br>
            <span style="color: var(--primary); font-weight: 500; font-size: 14px;">â†’ Result: High TGF-Î² + Hypoxia.</span><br>
            <div style="background: rgba(13,148,136,0.1); padding: 8px 12px; border-radius: 6px; margin-top: 6px; font-size: 13px; color: var(--primary-dark);">
                <strong>ğŸ’¡ AI Decision:</strong> Add <strong>TGFB_DNR</strong> (Dominant Negative Receptor). <br>
                <em>Reasoning: Shields CAR-T from TGF-Î² inhibition, converting the "stop" signal into a survival advantage.</em>
            </div>
        </div>

        <div class="step" style="margin-bottom: 16px;">
            <strong style="color: #0f172a;">Step 3: Safety & Toxicity</strong><br>
            <span style="color: var(--text-muted); font-size: 14px;">â€¢ Query: Is GPC3 expressed on normal tissues?</span><br>
            <span style="color: var(--primary); font-weight: 500; font-size: 14px;">â†’ Result: Low expression on normal liver/lung.</span><br>
            <div style="background: rgba(13,148,136,0.1); padding: 8px 12px; border-radius: 6px; margin-top: 6px; font-size: 13px; color: var(--primary-dark);">
                <strong>ğŸ’¡ AI Decision:</strong> Equip <strong>iCasp9 Safety Switch</strong>. <br>
                <em>Reasoning: Mandatory fail-safe to terminate therapy in case of severe on-target/off-tumor toxicity.</em>
            </div>
        </div>

        <div class="step">
            <strong style="color: #0f172a;">Step 4: Kinetics Tuning</strong><br>
            <span style="color: var(--text-muted); font-size: 14px;">â€¢ Query: Risk of exhaustion in solid tumor?</span><br>
            <span style="color: var(--primary); font-weight: 500; font-size: 14px;">â†’ Result: High. Requires serial killing persistence.</span><br>
            <div style="background: rgba(13,148,136,0.1); padding: 8px 12px; border-radius: 6px; margin-top: 6px; font-size: 13px; color: var(--primary-dark);">
                <strong>ğŸ’¡ AI Decision:</strong> Optimize for <strong>Fast Off-Rate (koff)</strong>. <br>
                <em>Reasoning: Prevents chronic signaling and exhaustion, allowing CAR-T cells to detach and engage multiple tumor targets sequentially.</em>
            </div>
        </div>
      </div>

      <h2 id="safety"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M12 22s8-4 8-10V5l-8-3-8 3v7c0 6 8 10 8 10z"/></svg></span><span class="lang-en">Safety & Efficacy</span><span class="lang-zh">å®‰å…¨ä¸æœ‰æ•ˆæ€§</span></h2>
      <p class="lang-en">Safety is engineered into the sequence, not just monitored in the clinic.</p>
      <p class="lang-zh">å®‰å…¨æ€§æ˜¯è®¾è®¡è¿›åºåˆ—ä¸­çš„ï¼Œè€Œä¸ä»…ä»…æ˜¯åœ¨ä¸´åºŠä¸­ç›‘æµ‹ã€‚</p>
      <ul class="lang-en">
        <li><strong>Safety Switches</strong> â€” <strong>iCasp9</strong> (Standard, >95% clearance), <strong>tEGFR</strong> (ADCC), <strong>RQR8</strong> (CD20 mimotope).</li>
        <li><strong>Logic Gating</strong> â€” <strong>SynNotch</strong> (AND gate for specificity), <strong>iCAR</strong> (Inhibitory CAR for normal tissue protection).</li>
        <li><strong>Toxicity Management</strong> â€” 4-1BB to reduce CRS peak; Local delivery to minimize systemic toxicity.</li>
      </ul>
      <ul class="lang-zh">
        <li><strong>å®‰å…¨å¼€å…³</strong> â€” <strong>iCasp9</strong> (æ ‡å‡†, >95% æ¸…é™¤), <strong>tEGFR</strong> (ADCC), <strong>RQR8</strong> (CD20 æ‹Ÿæ€è¡¨ä½)ã€‚</li>
        <li><strong>é€»è¾‘é—¨æ§</strong> â€” <strong>SynNotch</strong> (AND é—¨æå‡ç‰¹å¼‚æ€§), <strong>iCAR</strong> (æŠ‘åˆ¶å‹ CAR ä¿æŠ¤æ­£å¸¸ç»„ç»‡)ã€‚</li>
        <li><strong>æ¯’æ€§ç®¡ç†</strong> â€” ä½¿ç”¨ 4-1BB é™ä½ CRS å³°å€¼ï¼›å±€éƒ¨é€’é€å‡å°‘å…¨èº«æ¯’æ€§ã€‚</li>
      </ul>

      <h2 id="full-report"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M14 2H6a2 2 0 0 0-2 2v16a2 2 0 0 0 2 2h12a2 2 0 0 0 2-2V8z"/><polyline points="14 2 14 8 20 8"/><line x1="16" y1="13" x2="8" y2="13"/><line x1="16" y1="17" x2="8" y2="17"/><polyline points="10 9 9 9 8 9"/></svg></span><span class="lang-en">Full Design Report</span><span class="lang-zh">å®Œæ•´è®¾è®¡æŠ¥å‘Š</span></h2>
      <p class="lang-en">We deliver a comprehensive design package ready for synthesis and testing.</p>
      <p class="lang-zh">æˆ‘ä»¬äº¤ä»˜å¯ç›´æ¥ç”¨äºåˆæˆä¸æµ‹è¯•çš„å®Œæ•´è®¾è®¡åŒ…ã€‚</p>
      <ul class="lang-en">
        <li><strong>Construct Sequences</strong> â€” Optimized DNA/Amino Acid sequences for the full CAR construct (Binder-Hinge-TM-Signaling-Armor).</li>
        <li><strong>Vector Map</strong> â€” Plasmid/Lentiviral vector design with promoters (EF1Î±/MSCV) and regulatory elements.</li>
        <li><strong>Rationale</strong> â€” Detailed explanation of component selection based on disease context and target topology.</li>
        <li><strong>Experimental Plan</strong> â€” Recommended in vitro (killing, cytokine) and in vivo (mouse model) validation protocols.</li>
      </ul>
      <ul class="lang-zh">
        <li><strong>æ„å»ºä½“åºåˆ—</strong> â€” å®Œæ•´ CAR æ„å»ºä½“ï¼ˆBinder-é“°é“¾-è·¨è†œ-ä¿¡å·-é“ ç”²ï¼‰çš„ä¼˜åŒ– DNA/æ°¨åŸºé…¸åºåˆ—ã€‚</li>
        <li><strong>è½½ä½“å›¾è°±</strong> â€” å«å¯åŠ¨å­ (EF1Î±/MSCV) å’Œè°ƒæ§å…ƒä»¶çš„è´¨ç²’/æ…¢ç—…æ¯’è½½ä½“è®¾è®¡ã€‚</li>
        <li><strong>è®¾è®¡åŸç†</strong> â€” åŸºäºç–¾ç—…èƒŒæ™¯å’ŒæŠ—åŸæ‹“æ‰‘å­¦çš„ç»„ä»¶é€‰æ‹©è¯¦ç»†è¯´æ˜ã€‚</li>
        <li><strong>å®éªŒæ–¹æ¡ˆ</strong> â€” æ¨èçš„ä½“å¤–ï¼ˆæ€ä¼¤ã€ç»†èƒå› å­ï¼‰åŠä½“å†…ï¼ˆå°é¼ æ¨¡å‹ï¼‰éªŒè¯æ–¹æ¡ˆã€‚</li>
      </ul>

      <h2 id="submit"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><line x1="22" y1="2" x2="11" y2="13"/><polygon points="22 2 15 22 11 13 2 9 22 2"/></svg></span><span class="lang-en">Submit Inquiry</span><span class="lang-zh">æäº¤å’¨è¯¢</span></h2>
      <p class="lang-en">Tell us about your target and disease indication. We will provide a tailored CAR design proposal.</p>
      <p class="lang-zh">è¯·å‘ŠçŸ¥æ‚¨çš„é¶ç‚¹å’Œç–¾ç—…é€‚åº”ç—‡ã€‚æˆ‘ä»¬å°†æä¾›å®šåˆ¶åŒ–çš„ CAR è®¾è®¡æ–¹æ¡ˆã€‚</p>

      <div class="form-section">
        <form id="inquiry-form" action="https://formspree.io/f/mnjblezr" method="POST">
          <input type="hidden" name="_subject" value="InSynBio CAR-T Inquiry">
          <input type="hidden" name="_next" value="https://insynbio.com/thanks.html">
          
          <h3 style="margin-top: 0; margin-bottom: 20px;"><span class="lang-en">Project Details</span><span class="lang-zh">é¡¹ç›®è¯¦æƒ…</span></h3>
          <div class="form-row">
            <div class="form-group">
              <label><span class="lang-en">Disease Type *</span><span class="lang-zh">ç–¾ç—…ç±»å‹ *</span></label>
              <select name="disease_type" required>
                <option value="" disabled selected>Select...</option>
                <option value="solid">Solid Tumor (å®ä½“ç˜¤)</option>
                <option value="liquid">Hematologic Malignancy (è¡€æ¶²ç˜¤)</option>
                <option value="autoimmune">Autoimmune Disease (è‡ªèº«å…ç–«)</option>
                <option value="other">Other (å…¶ä»–)</option>
              </select>
            </div>
            <div class="form-group">
              <label><span class="lang-en">Target Antigen *</span><span class="lang-zh">é¶ç‚¹æŠ—åŸ *</span></label>
              <input type="text" name="target" placeholder="e.g., GPC3, BCMA, CD19" required>
            </div>
          </div>

          <div class="form-group full">
            <label><span class="lang-en">Service Requirements</span><span class="lang-zh">æœåŠ¡éœ€æ±‚</span></label>
            <div class="check-group">
              <div class="check-item"><input type="checkbox" name="services" id="s1" value="design"><label for="s1"><span class="lang-en">De Novo CAR Design</span><span class="lang-zh">ä»å¤´ CAR è®¾è®¡</span></label></div>
              <div class="check-item"><input type="checkbox" name="services" id="s2" value="optimization"><label for="s2"><span class="lang-en">Sequence Optimization (Humanization/Affinity)</span><span class="lang-zh">åºåˆ—ä¼˜åŒ–ï¼ˆäººæºåŒ–/äº²å’ŒåŠ›ï¼‰</span></label></div>
              <div class="check-item"><input type="checkbox" name="services" id="s3" value="cro"><label for="s3"><span class="lang-en">CRO Validation (In vitro/In vivo)</span><span class="lang-zh">CRO éªŒè¯ï¼ˆä½“å¤–/ä½“å†…ï¼‰</span></label></div>
              <div class="check-item"><input type="checkbox" name="services" id="s4" value="full"><label for="s4"><span class="lang-en">Full End-to-End Package</span><span class="lang-zh">å®Œæ•´ç«¯åˆ°ç«¯åŒ…</span></label></div>
            </div>
          </div>

          <div class="form-group full">
            <label><span class="lang-en">Chassis / Delivery Preference (Optional)</span><span class="lang-zh">åº•ç›˜/é€’é€åå¥½ï¼ˆå¯é€‰ï¼‰</span></label>
            <div class="check-group">
              <div class="check-item"><input type="checkbox" name="chassis" id="c1" value="cart"><label for="c1"><span class="lang-en">CAR-T (Î±Î²)</span><span class="lang-zh">CAR-T (Î±Î²)</span></label></div>
              <div class="check-item"><input type="checkbox" name="chassis" id="c2" value="carnk"><label for="c2"><span class="lang-en">CAR-NK</span><span class="lang-zh">CAR-NK</span></label></div>
              <div class="check-item"><input type="checkbox" name="chassis" id="c3" value="carm"><label for="c3"><span class="lang-en">CAR-M</span><span class="lang-zh">CAR-M</span></label></div>
              <div class="check-item"><input type="checkbox" name="chassis" id="c4" value="gamma"><label for="c4"><span class="lang-en">Î³Î´ T</span><span class="lang-zh">Î³Î´ T</span></label></div>
              <div class="check-item"><input type="checkbox" name="chassis" id="c5" value="invivo"><label for="c5"><span class="lang-en">In Vivo CAR (e.g. LNP-mRNA)</span><span class="lang-zh">ä½“å†… CARï¼ˆå¦‚ LNP-mRNAï¼‰</span></label></div>
            </div>
          </div>

          <div class="form-group full">
            <label for="message"><span class="lang-en">Additional context (e.g., binder sequence, specific constraints)</span><span class="lang-zh">è¡¥å……èƒŒæ™¯ï¼ˆå¦‚ï¼šBinder åºåˆ—ã€ç‰¹å®šçº¦æŸï¼‰</span></label>
            <textarea id="message" name="message" placeholder="Describe your project goals..." style="min-height: 100px;"></textarea>
          </div>
          <div class="form-group full" style="margin-top: 16px;">
            <div class="check-group">
              <div class="check-item">
                <input type="checkbox" name="newsletter" id="newsletter" value="yes">
                <label for="newsletter">
                  <span class="lang-en">Join mailing list for news and service updates</span>
                  <span class="lang-zh">åŠ å…¥é‚®ä»¶ç»„ï¼Œè·å–åŠ¨æ€ä¸æœåŠ¡æ›´æ–°</span>
                </label>
              </div>
            </div>
          </div>

          <h3 style="margin-top: 24px; margin-bottom: 20px;"><span class="lang-en">Contact Information</span><span class="lang-zh">è”ç³»ä¿¡æ¯</span></h3>
          <div class="form-row">
            <div class="form-group">
              <label for="fname"><span class="lang-en">First Name *</span><span class="lang-zh">å *</span></label>
              <input type="text" id="fname" name="fname" required>
            </div>
            <div class="form-group">
              <label for="lname"><span class="lang-en">Last Name *</span><span class="lang-zh">å§“ *</span></label>
              <input type="text" id="lname" name="lname" required>
            </div>
          </div>
          <div class="form-row">
            <div class="form-group">
              <label for="org"><span class="lang-en">Organization *</span><span class="lang-zh">å•ä½ *</span></label>
              <input type="text" id="org" name="org" required>
            </div>
            <div class="form-group">
              <label for="email">Email *</label>
              <input type="email" id="email" name="email" required>
            </div>
          </div>
          
          <div style="margin-top: 24px;">
            <button type="submit" class="btn"><span class="lang-en">Submit Inquiry</span><span class="lang-zh">æäº¤å’¨è¯¢</span></button>
          </div>
        </form>
      </div>

      <!-- Contact -->
      <h2 id="contact"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M4 4h16c1.1 0 2 .9 2 2v12c0 1.1-.9 2-2 2H4c-1.1 0-2-.9-2-2V6c0-1.1.9-2 2-2z"/><polyline points="22,6 12,13 2,6"/></svg></span><span class="lang-en">Contact</span><span class="lang-zh">è”ç³»æ–¹å¼</span></h2>
      <p class="lang-en">For inquiries, please submit the form above or email us directly:</p>
      <p class="lang-zh">å’¨è¯¢è¯·ä½¿ç”¨ä¸Šæ–¹è¡¨å•æˆ–ç›´æ¥å‘é€é‚®ä»¶ï¼š</p>
      <p style="margin: 16px 0;"><a href="mailto:contact@insynbio.com" style="font-size: 18px; font-weight: 600; color: var(--primary);">contact@insynbio.com</a></p>
      <p class="lang-en" style="color: var(--text-muted); font-size: 14px;">We typically respond within 1â€“2 business days.</p>
      <p class="lang-zh" style="color: var(--text-muted); font-size: 14px;">æˆ‘ä»¬é€šå¸¸åœ¨ 1â€“2 ä¸ªå·¥ä½œæ—¥å†…å›å¤ã€‚</p>
      
      <footer class="site-footer">
        <p>Â© 2026 InSynBio Â· <a href="https://insynbio.com">insynbio.com</a> Â· <a href="mailto:contact@insynbio.com">contact@insynbio.com</a></p>
      </footer>
    </main>
  </div>
  <script>
    document.querySelectorAll('.nav-link').forEach(a => {
      a.addEventListener('click', function(e) {
        e.preventDefault();
        const id = this.getAttribute('href').slice(1);
        document.getElementById(id)?.scrollIntoView({ behavior: 'smooth' });
        document.querySelectorAll('.nav-link').forEach(l => l.classList.remove('active'));
        this.classList.add('active');
      });
    });
    const sections = ['platform','library','strategy','engineering','example','safety','full-report','submit','contact'];
    const observer = new IntersectionObserver((entries) => {
      entries.forEach(entry => {
        if (!entry.isIntersecting) return;
        const id = entry.target.id;
        document.querySelectorAll('.nav-link').forEach(a => {
          a.classList.toggle('active', a.getAttribute('href') === '#' + id);
        });
      });
    }, { rootMargin: '-20% 0px -60% 0px' });
    sections.forEach(id => { const el = document.getElementById(id); if (el) observer.observe(el); });
    (function() {
      const KEY = 'insynbio-lang';
      const ZH_REGIONS = ['CN', 'TW', 'HK', 'MO'];
      function applyLang(lang) {
        document.body.setAttribute('data-lang', lang);
        document.querySelectorAll('.lang-btn').forEach(b => {
          b.classList.toggle('active', b.dataset.lang === lang);
        });
        document.title = lang === 'zh' ? 'æ™ºæ…§ CAR-T è®¾è®¡ | InSynBio' : 'Smart CAR-T Design | InSynBio';
      }
      var saved = localStorage.getItem(KEY);
      if (saved === 'zh' || saved === 'en') {
        applyLang(saved);
      } else {
        var initial = (navigator.language && navigator.language.toLowerCase().indexOf('zh') === 0) ? 'zh' : 'en';
        applyLang(initial);
        fetch('https://ipapi.co/json/').then(function(r) { return r.json(); }).then(function(data) {
          var code = (data && data.country_code) ? data.country_code.toUpperCase() : '';
          var lang = ZH_REGIONS.indexOf(code) >= 0 ? 'zh' : 'en';
          localStorage.setItem(KEY, lang);
          applyLang(lang);
        }).catch(function() {});
      }
      document.querySelectorAll('.lang-btn').forEach(btn => {
        btn.addEventListener('click', function(e) {
          e.preventDefault();
          const lang = this.dataset.lang;
          localStorage.setItem(KEY, lang);
          applyLang(lang);
        });
      });
    })();
    // Form submission
    const form = document.getElementById('inquiry-form');
    if (form) {
      form.addEventListener('submit', function(e) {
        e.preventDefault();
        const btn = form.querySelector('button[type="submit"]');
        const originalText = btn.innerText;
        btn.disabled = true;
        btn.innerText = document.body.getAttribute('data-lang') === 'zh' ? 'æäº¤ä¸­...' : 'Submitting...';

        const formData = new FormData(form);
        fetch(form.action, {
          method: 'POST',
          body: formData,
          headers: { 'Accept': 'application/json' }
        }).then(response => {
          if (response.ok) {
            window.location.href = 'thanks.html';
          } else {
            alert("Oops! There was a problem submitting your form");
            btn.disabled = false;
            btn.innerText = originalText;
          }
        }).catch(error => {
          alert("Oops! There was a problem submitting your form");
          btn.disabled = false;
          btn.innerText = originalText;
        });
      });
    }
  </script>
</body>
</html>
